Impact Factor
3.73
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.62
1,368 total citations
h5-index
40
h5 depth signal
Cited share
76.0%
310 of 408
Total citations
1,368
Citation footprint
Metric signal
3.40
External metric anchor
Self-citation
3.1%
43 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Italy
567
China
460
United States
140
United Kingdom
104
Germany
95
Citing Fields of Research
Diabetes
1,531
Obstetrics/Gynecology
198
Ophthalmology
171
Endocrinology & Metabolism
129
Nutrition & Dietetics
102
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,926
Articles tracked across the journal lifetime
Indexed publication set
408
310 cited publications
Last 12 months
213
17.8 publications/month
Open access share
30.0%
64 OA publications in the last year
Leading citing country
Italy
567 citing publications
Leading citing field
Diabetes
1,531 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v28n2, 1991-
v28n2, 1991-
Active Coverage
Research Focus & Classification
Indexed Subjects
Diabetes
Broad Categories
Endocrinology
Diabetes
MeSH Descriptors
Diabetes Mellitus
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1007/s00592-026-02811-4
Open DOI
Aldosterone–mineralocorticoid receptor signaling and residual cardiorenal risk in type 2 diabetes
Clinically important cardiorenal risk persists in type 2 diabetes mellitus (T2DM) despite major advances in metabolic and organ-protective therapy. This narrative review evaluates aldosterone-mineralocorticoid receptor (MR) signaling as ...
03
DOI 10.1007/s00592-026-02812-3
Open DOI
GLP-1 receptor agonists and hair loss: adverse effect, epiphenomenon, or therapeutic paradox?
Objective: Incretin-based therapies, including glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual/triple agonists, have revolutionized the management of obesity and type 2 diabetes. However, hair loss has emerged as an advers...
04
DOI 10.1007/s00592-026-02809-y
Open DOI
Risk of recurrent acute pancreatitis with GLP-1 receptor agonists after prior pancreatitis: a systematic review
Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are widely used for patients with type 2 diabetes (T2D) and obesity. However, their safety in patients with prior pancreatitis remains uncertain. This systematic review ...
05
DOI 10.1007/s00592-026-02814-1
Open DOI
miR-142-3p overexpression targets CLTA and impairs clathrin-mediated endocytosis in HLSECs induced by high glucose
Objective This study aims to explore the effect of miR-142-3p on the endocytosis in human liver sinusoidal endothelial cells (HLSECs) induced by high glucose and to investigate the underlying mechanisms. Methods Multi-database target pre...
06
DOI 10.1007/s00592-026-02816-z
Open DOI
Gestational diabetes mellitus in Italian diabetes clinics: clinical characteristics, screening practices and management from the amd annals registry
Background Gestational diabetes mellitus (GDM) is one of the most common complications of pregnancy and is associated with adverse maternal and neonatal outcomes. Nationwide real-world data describing characteristics , screening practice...
07
08
09
DOI 10.1007/s00592-026-02808-z
Open DOI
Targeting ceramides in metabolic syndrome: recent advances and therapeutic opportunities
10
DOI 10.1007/s00592-026-02803-4
Open DOI
Clinical significance and biological role of circFNDC3B in diabetic retinopathy
Bibliographical & Catalog Notes
Title from cover.
Called also: Vol. 28, no. 2- .
Also available online.
Continues: Acta diabetologica latina.
Vol. 28, no. 2 (OCT 1991)19911210 Notice published Printed on acid-free paper